echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > World Gut Health Day Gut Health Research Inventory!

    World Gut Health Day Gut Health Research Inventory!

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The intestine is known as the "second brain" of the human bo.
    It is not only the largest digestive organ of the human body, responsible for the digestion and absorption of nutrients, but also affects many aspects such as human metabolism and emotional regulation; at the same time, the intestine is still important Scientific research shows that 70% of the immune cells in the human body are derived from the intestinal system; therefore, intestinal health is related to the health of the entire human body, but at present, more than 90% of Chinese people suffer from intestinal health proble.
    Health issues are not to be underestimated!The gut microbiota in the gut is the main microbial population that maintains gut health, and its structure varies among individuals and in different health states, which can easily induce a series of health proble.
    How to maintain and regulate the balance of intestinal flora is the key to maintaining intestinal health and even human heal.
    As an important microecological preparation, probiotics can effectively regulate the structure of intestinal flora by colonizing the human intestine, and exert corresponding probiotic effec.
    It is an important choice to protect human heal.
    As 29 World Gut Health Day is approaching, let's take a look at what Ketuo Bio, as the first listed company in China's probiotic industry, has made research on probiotics in intestinal health over the years!Clinical study of Bifidobacterium lactis V9 on constipation and diarrhea
    The People's Hospital of Inner Mongolia Autonomous Region selected 153 patients with constipation and diarrhea for a 3-week clinical trial, taking Bifidobacterium lactis V9 to detect defecation and intestinal flo.
    The results showed that the average defecation frequency of patients with constipation was significantly increased after taking Bifidobacterium lactis V9; the average defecation frequency of patients with diarrhea was significantly decreased after taking Bifidobacterium lactis V9; the frequency of defecation in patients with constipation and diarrhea after taking Bifidobacterium lactis V9 for many days was significantly higher than that of patients with constipation and diarrh.
    The fecal status returned to normal; the intestinal flora was also improved after taking Bifidobacterium lactis V9, and Bifidobacterium/Enterobacter was greater thanThis shows that Bifidobacterium lactis V9 can effectively improve constipation and diarrhea, and the effective rates can reach 94% and 93%, respectively; and effectively improve the structure of intestinal flo.
    Clinical study of probiotic preparation Probio-Fit® for adjuvant treatment of irritable bowel syndrome (IBS)
    A 28-day clinical trial was conducted on 45 IBS patients at the Chinese People's Liberation Army Navy General Hospital, who were randomly divided into a control group (21) and a probiotic group (24), with the probiotic group taking the probiotic preparation Probio-Fit® ( Containing Lactobacillus casei Zhang, Bifidobacterium lactis V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and feces and blood samples were collected from patients before and after treatment for testi.
    The results showed that the concentrations of IL-8, IL-6, TNF-α and lipopolysaccharide LPS in the blood of patients taking the probiotic preparation Probio-Fit® were significantly decreased, and the IBS symptom score was significantly improved; The diversity of bacterial flora can reduce the abundance of harmful bacteria and effectively prevent the decline of beneficial bacteria caused by drug treatme.
    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBS to achieve the effect of adjuvant therapy, significantly reduce the content of pathogenic cytokines, greatly improve the symptoms of IBS, and effectively regulate the intestinal flora and maintain the intestinal flo.
    Tao heal.
    Clinical study of probiotic preparation Probio-Fit® for adjuvant therapy of inflammatory bowel disease (IBD)
    A 12-week clinical trial was conducted on 30 UC patients at the Affiliated Hospital of Inner Mongolia Medical University, who were randomly divided into a control group and a probiotics gro.
    Bacillus plantarum V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and the patients were clinically diagnosed and tested for intestinal microb.
    The results showed that the frequency of defecation decreased significantly in patients taking the probiotic preparation Probio-Fit®, and clinical indicators such as rectal bleeding, UC remission rate (967%) were better than those of the control group (623%), and the UCDAI score also decreased significantly; On the one hand, the probiotic preparation Probio-Fit® maintained the steady state of intestinal flora and increased the content of beneficial bacteria such as Weisseria, Ruminococcus and Eubacteri.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBD, so as to achieve the role of adjuvant therapy, significantly relieve the clinical manifestations of UC patients, improve the symptoms of IBD, reduce the frequency of defecation and bleeding, and the remission rate is as high as 967% ! On the other hand, the probiotic preparation Probio-Fit® can also effectively regulate the intestinal flora of patients, maintain the homeostasis of the flora, and increase the content of beneficial bacter.

    Not only that, Ketuo Bio has also conducted a large number of scientific research and clinical trials in the field of intestinal health, which also includes the regulation of intestinal flora of special populations by probiotics in different regions, people of different ages, even sailing oceans, antibiotic abuse, e.

    The investigation of the situation, as well as the clinical investigation of probiotics on major health problems such as colon cancer adjuvant therapy and intractable constipation, the relevant clinical research has been carried out and is in progress!Ketuo Bio has always adhered to scientific research and continuous innovation, and cooperated with many domestic universities, research institutes and enterprises to isolate, identify and preserve 21268 strains of lactic acid bacteria from naturally fermented foods, healthy people's intestines and breast milk from all over Asia, and built an Asian The largest resource bank of lactic acid bacteria strai.

    A total of 60 clinical trials have been carried out in cooperation with more than ten tertiary hospitals in China, and the effect is remarkab.
    In the future, Ketuo Bio will continue to innovate, continue to create "Chinese bacteria" and adhere to the industrial application of its own strains to help the healthy development of China's probiotics industry!

     
    Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Netwo.

    Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and te.

    Readers are only for reference and please Verify the relevant content yourse.

       Copyright Notice
        Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original auth.

    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicat.

    Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient eviden.

    , bio149 will be deleted within 12 hours after confirmati.

    Users are welcome to submit original articles to 86371366@.

    com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the send.

     
      The intestine is known as the "second brain" of the human bo.

    It is not only the largest digestive organ of the human body, responsible for the digestion and absorption of nutrients, but also affects many aspects such as human metabolism and emotional regulation; at the same time, the intestine is still important Scientific research shows that 70% of the immune cells in the human body are derived from the intestinal system; therefore, intestinal health is related to the health of the entire human body, but at present, more than 90% of Chinese people suffer from intestinal health proble.

    Health issues are not to be underestimated!   The gut microbiota in the gut is the main microbial population that maintains gut health, and its structure varies among individuals and in different health states, which can easily induce a series of health proble.

    How to maintain and regulate the balance of intestinal flora is the key to maintaining intestinal health and even human heal.

    As an important microecological preparation, probiotics can effectively regulate the structure of intestinal flora by colonizing the human intestine, and exert corresponding probiotic effec.

    It is an important choice to protect human heal.

      As 29 World Gut Health Day is approaching, let's take a look at what Ketuo Bio, as the first listed company in China's probiotic industry, has made research on probiotics in intestinal health over the years!   Clinical study of Bifidobacterium lactis V9 on constipation and diarrhea
      The People's Hospital of Inner Mongolia Autonomous Region selected 153 patients with constipation and diarrhea for a 3-week clinical trial, taking Bifidobacterium lactis V9 to detect defecation and intestinal flo.

    The results showed that the average defecation frequency of patients with constipation was significantly increased after taking Bifidobacterium lactis V9; the average defecation frequency of patients with diarrhea was significantly decreased after taking Bifidobacterium lactis V9; the frequency of defecation in patients with constipation and diarrhea after taking Bifidobacterium lactis V9 for many days was significantly higher than that of patients with constipation and diarrh.

    The fecal status returned to normal; the intestinal flora was also improved after taking Bifidobacterium lactis V9, and Bifidobacterium/Enterobacter was greater than This shows that Bifidobacterium lactis V9 can effectively improve constipation and diarrhea, and the effective rates can reach 94% and 93%, respectively; and effectively improve the structure of intestinal flo.

      Clinical study of probiotic preparation Probio-Fit® for adjuvant treatment of irritable bowel syndrome (IBS)
      A 28-day clinical trial was conducted on 45 IBS patients at the Chinese People's Liberation Army Navy General Hospital, who were randomly divided into a control group (21) and a probiotic group (24), with the probiotic group taking the probiotic preparation Probio-Fit® ( Containing Lactobacillus casei Zhang, Bifidobacterium lactis V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and feces and blood samples were collected from patients before and after treatment for testi.

    The results showed that the concentrations of IL-8, IL-6, TNF-α and lipopolysaccharide LPS in the blood of patients taking the probiotic preparation Probio-Fit® were significantly decreased, and the IBS symptom score was significantly improved; The diversity of bacterial flora can reduce the abundance of harmful bacteria and effectively prevent the decline of beneficial bacteria caused by drug treatme.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBS to achieve the effect of adjuvant therapy, significantly reduce the content of pathogenic cytokines, greatly improve the symptoms of IBS, and effectively regulate the intestinal flora and maintain the intestinal flo.

    Tao heal.

      Clinical study of probiotic preparation Probio-Fit® for adjuvant therapy of inflammatory bowel disease (IBD)
      A 12-week clinical trial was conducted on 30 UC patients at the Affiliated Hospital of Inner Mongolia Medical University, who were randomly divided into a control group and a probiotics gro.

    Bacillus plantarum V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and the patients were clinically diagnosed and tested for intestinal microb.

    The results showed that the frequency of defecation decreased significantly in patients taking the probiotic preparation Probio-Fit®, and clinical indicators such as rectal bleeding, UC remission rate (967%) were better than those of the control group (623%), and the UCDAI score also decreased significantly; On the one hand, the probiotic preparation Probio-Fit® maintained the steady state of intestinal flora and increased the content of beneficial bacteria such as Weisseria, Ruminococcus and Eubacteri.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBD, so as to achieve the role of adjuvant therapy, significantly relieve the clinical manifestations of UC patients, improve the symptoms of IBD, reduce the frequency of defecation and bleeding, and the remission rate is as high as 967% ! On the other hand, the probiotic preparation Probio-Fit® can also effectively regulate the intestinal flora of patients, maintain the homeostasis of the flora, and increase the content of beneficial bacter.

      Not only that, Ketuo Bio has also conducted a large number of scientific research and clinical trials in the field of intestinal health, which also includes the regulation of intestinal flora of special populations by probiotics in different regions, people of different ages, even sailing oceans, antibiotic abuse, e.

    The investigation of the situation, as well as the clinical investigation of probiotics on major health problems such as colon cancer adjuvant therapy and intractable constipation, the relevant clinical research has been carried out and is in progress!   Ketuo Bio has always adhered to scientific research and continuous innovation, and cooperated with many domestic universities, research institutes and enterprises to isolate, identify and preserve 21268 strains of lactic acid bacteria from naturally fermented foods, healthy people's intestines and breast milk from all over Asia, and built an Asian The largest resource bank of lactic acid bacteria strai.

    A total of 60 clinical trials have been carried out in cooperation with more than ten tertiary hospitals in China, and the effect is remarkab.
    In the future, Ketuo Bio will continue to innovate, continue to create "Chinese bacteria" and adhere to the industrial application of its own strains to help the healthy development of China's probiotics industry!
     

     
       Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Netwo.

    Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and te.

    Readers are only for reference and please Verify the relevant content yourse.

     
       Copyright Notice
        Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original auth.

    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicat.

    Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient eviden.

    , bio149 will be deleted within 12 hours after confirmati.

    Users are welcome to submit original articles to 86371366@.

    com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the send.

     
      The intestine is known as the "second brain" of the human bo.

    It is not only the largest digestive organ of the human body, responsible for the digestion and absorption of nutrients, but also affects many aspects such as human metabolism and emotional regulation; at the same time, the intestine is still important Scientific research shows that 70% of the immune cells in the human body are derived from the intestinal system; therefore, intestinal health is related to the health of the entire human body, but at present, more than 90% of Chinese people suffer from intestinal health proble.

    Health issues are not to be underestimated!   The gut microbiota in the gut is the main microbial population that maintains gut health, and its structure varies among individuals and in different health states, which can easily induce a series of health proble.

    How to maintain and regulate the balance of intestinal flora is the key to maintaining intestinal health and even human heal.

    As an important microecological preparation, probiotics can effectively regulate the structure of intestinal flora by colonizing the human intestine, and exert corresponding probiotic effec.

    It is an important choice to protect human heal.

      As 29 World Gut Health Day is approaching, let's take a look at what Ketuo Bio, as the first listed company in China's probiotic industry, has made research on probiotics in intestinal health over the years!   Clinical study of Bifidobacterium lactis V9 on constipation and diarrhea
      The People's Hospital of Inner Mongolia Autonomous Region selected 153 patients with constipation and diarrhea for a 3-week clinical trial, taking Bifidobacterium lactis V9 to detect defecation and intestinal flo.

    The results showed that the average defecation frequency of patients with constipation was significantly increased after taking Bifidobacterium lactis V9; the average defecation frequency of patients with diarrhea was significantly decreased after taking Bifidobacterium lactis V9; the frequency of defecation in patients with constipation and diarrhea after taking Bifidobacterium lactis V9 for many days was significantly higher than that of patients with constipation and diarrh.

    The fecal status returned to normal; the intestinal flora was also improved after taking Bifidobacterium lactis V9, and Bifidobacterium/Enterobacter was greater than This shows that Bifidobacterium lactis V9 can effectively improve constipation and diarrhea, and the effective rates can reach 94% and 93%, respectively; and effectively improve the structure of intestinal flo.

      Clinical study of probiotic preparation Probio-Fit® for adjuvant treatment of irritable bowel syndrome (IBS)
      A 28-day clinical trial was conducted on 45 IBS patients at the Chinese People's Liberation Army Navy General Hospital, who were randomly divided into a control group (21) and a probiotic group (24), with the probiotic group taking the probiotic preparation Probio-Fit® ( Containing Lactobacillus casei Zhang, Bifidobacterium lactis V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and feces and blood samples were collected from patients before and after treatment for testi.

    The results showed that the concentrations of IL-8, IL-6, TNF-α and lipopolysaccharide LPS in the blood of patients taking the probiotic preparation Probio-Fit® were significantly decreased, and the IBS symptom score was significantly improved; The diversity of bacterial flora can reduce the abundance of harmful bacteria and effectively prevent the decline of beneficial bacteria caused by drug treatme.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBS to achieve the effect of adjuvant therapy, significantly reduce the content of pathogenic cytokines, greatly improve the symptoms of IBS, and effectively regulate the intestinal flora and maintain the intestinal flo.

    Tao heal.

      Clinical study of probiotic preparation Probio-Fit® for adjuvant therapy of inflammatory bowel disease (IBD)
      A 12-week clinical trial was conducted on 30 UC patients at the Affiliated Hospital of Inner Mongolia Medical University, who were randomly divided into a control group and a probiotics gro.

    Bacillus plantarum V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and the patients were clinically diagnosed and tested for intestinal microb.

    The results showed that the frequency of defecation decreased significantly in patients taking the probiotic preparation Probio-Fit®, and clinical indicators such as rectal bleeding, UC remission rate (967%) were better than those of the control group (623%), and the UCDAI score also decreased significantly; On the one hand, the probiotic preparation Probio-Fit® maintained the steady state of intestinal flora and increased the content of beneficial bacteria such as Weisseria, Ruminococcus and Eubacteri.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBD, so as to achieve the role of adjuvant therapy, significantly relieve the clinical manifestations of UC patients, improve the symptoms of IBD, reduce the frequency of defecation and bleeding, and the remission rate is as high as 967% ! On the other hand, the probiotic preparation Probio-Fit® can also effectively regulate the intestinal flora of patients, maintain the homeostasis of the flora, and increase the content of beneficial bacter.

      Not only that, Ketuo Bio has also conducted a large number of scientific research and clinical trials in the field of intestinal health, which also includes the regulation of intestinal flora of special populations by probiotics in different regions, people of different ages, even sailing oceans, antibiotic abuse, e.

    The investigation of the situation, as well as the clinical investigation of probiotics on major health problems such as colon cancer adjuvant therapy and intractable constipation, the relevant clinical research has been carried out and is in progress!   Ketuo Bio has always adhered to scientific research and continuous innovation, and cooperated with many domestic universities, research institutes and enterprises to isolate, identify and preserve 21268 strains of lactic acid bacteria from naturally fermented foods, healthy people's intestines and breast milk from all over Asia, and built an Asian The largest resource bank of lactic acid bacteria strai.

    A total of 60 clinical trials have been carried out in cooperation with more than ten tertiary hospitals in China, and the effect is remarkab.
    In the future, Ketuo Bio will continue to innovate, continue to create "Chinese bacteria" and adhere to the industrial application of its own strains to help the healthy development of China's probiotics industry!
     

     
       Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Netwo.

    Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and te.

    Readers are only for reference and please Verify the relevant content yourse.

     
       Copyright Notice
        Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original auth.

    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicat.

    Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient eviden.

    , bio149 will be deleted within 12 hours after confirmati.

    Users are welcome to submit original articles to 86371366@.

    com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the send.

     

      The intestine is known as the "second brain" of the human bo.

    It is not only the largest digestive organ of the human body, responsible for the digestion and absorption of nutrients, but also affects many aspects such as human metabolism and emotional regulation; at the same time, the intestine is still important Scientific research shows that 70% of the immune cells in the human body are derived from the intestinal system; therefore, intestinal health is related to the health of the entire human body, but at present, more than 90% of Chinese people suffer from intestinal health proble.

    Health issues are not to be underestimated!   The gut microbiota in the gut is the main microbial population that maintains gut health, and its structure varies among individuals and in different health states, which can easily induce a series of health proble.

    How to maintain and regulate the balance of intestinal flora is the key to maintaining intestinal health and even human heal.

    As an important microecological preparation, probiotics can effectively regulate the structure of intestinal flora by colonizing the human intestine, and exert corresponding probiotic effec.

    It is an important choice to protect human heal.

      As 29 World Gut Health Day is approaching, let's take a look at what Ketuo Bio, as the first listed company in China's probiotic industry, has made research on probiotics in intestinal health over the years!   Clinical study of Bifidobacterium lactis V9 on constipation and diarrhea
      The People's Hospital of Inner Mongolia Autonomous Region selected 153 patients with constipation and diarrhea for a 3-week clinical trial, taking Bifidobacterium lactis V9 to detect defecation and intestinal flo.

    The results showed that the average defecation frequency of patients with constipation was significantly increased after taking Bifidobacterium lactis V9; the average defecation frequency of patients with diarrhea was significantly decreased after taking Bifidobacterium lactis V9; the frequency of defecation in patients with constipation and diarrhea after taking Bifidobacterium lactis V9 for many days was significantly higher than that of patients with constipation and diarrh.

    The fecal status returned to normal; the intestinal flora was also improved after taking Bifidobacterium lactis V9, and Bifidobacterium/Enterobacter was greater than This shows that Bifidobacterium lactis V9 can effectively improve constipation and diarrhea, and the effective rates can reach 94% and 93%, respectively; and effectively improve the structure of intestinal flo.

      Clinical study of probiotic preparation Probio-Fit® for adjuvant treatment of irritable bowel syndrome (IBS)

      A 12-week clinical trial was conducted on 30 UC patients at the Affiliated Hospital of Inner Mongolia Medical University, who were randomly divided into a control group and a probiotics gro.

    Bacillus plantarum V9 and Lactobacillus plantarum P-8) and conventional drugs, the control group was treated with conventional drugs alone, and the patients were clinically diagnosed and tested for intestinal microb.

    The results showed that the frequency of defecation decreased significantly in patients taking the probiotic preparation Probio-Fit®, and clinical indicators such as rectal bleeding, UC remission rate (967%) were better than those of the control group (623%), and the UCDAI score also decreased significantly; On the one hand, the probiotic preparation Probio-Fit® maintained the steady state of intestinal flora and increased the content of beneficial bacteria such as Weisseria, Ruminococcus and Eubacteri.

    This shows that the probiotic preparation Probio-Fit® combined with conventional drugs can better treat IBD, so as to achieve the role of adjuvant therapy, significantly relieve the clinical manifestations of UC patients, improve the symptoms of IBD, reduce the frequency of defecation and bleeding, and the remission rate is as high as 967% ! On the other hand, the probiotic preparation Probio-Fit® can also effectively regulate the intestinal flora of patients, maintain the homeostasis of the flora, and increase the content of beneficial bacter.

      Not only that, Ketuo Bio has also conducted a large number of scientific research and clinical trials in the field of intestinal health, which also includes the regulation of intestinal flora of special populations by probiotics in different regions, people of different ages, even sailing oceans, antibiotic abuse, e.

    The investigation of the situation, as well as the clinical investigation of probiotics on major health problems such as colon cancer adjuvant therapy and intractable constipation, the relevant clinical research has been carried out and is in progress!   Ketuo Bio has always adhered to scientific research and continuous innovation, and cooperated with many domestic universities, research institutes and enterprises to isolate, identify and preserve 21268 strains of lactic acid bacteria from naturally fermented foods, healthy people's intestines and breast milk from all over Asia, and built an Asian The largest resource bank of lactic acid bacteria strai.

    A total of 60 clinical trials have been carried out in cooperation with more than ten tertiary hospitals in China, and the effect is remarkab.
    In the future, Ketuo Bio will continue to innovate, continue to create "Chinese bacteria" and adhere to the industrial application of its own strains to help the healthy development of China's probiotics industry!
     


     
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.